Samenvatting
Insulin degludec (IDeg) is a new ultra-long-acting basal insulin shown to have low day-to-day variability in a euglycemic clamp study. In this post-hoc meta-analysis of patients with T2D, we compared day-to-day variability in mean selfmeasured blood glucose (derived from 9-point profiles; 9P-SMPG) between IDeg and insulin glargine (IGlar).
Author information
Authors and Affiliations
Additional information
Miami, FL, London, ON, Canada, Cardiff, United Kingdom, Søborg, Denmark, Graz, Austria
About this article
Cite this article
Meneghini, L., Harris, S., Evans, M. et al. 7.3. Lower Within-Subject Variability in Mean Blood Glucose Concentration with Insulin Degludec vs. Insulin Glargine: A Meta-Analysis of Patients with T2D (914-P). NED. TIJDSCHR. DIABET. 11, 99–100 (2013). https://doi.org/10.1007/s12467-013-0054-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12467-013-0054-2